在糖尿病患者中解决双眼透视症:皮质类固醇的有效性
Yulia Shtanko1, Maria Stevens1
1Humanities, Health, and Society, Florida International University, Herbert Wertheim College of Medicine, Miami, USA.
Cureus
|August 26, 2024
概括
本案例研究详细介绍了一名患有双眼视障碍的糖尿病患者,其症状在使用普得尼松后得到改善. 它强调皮质类固醇作为糖尿病相关视力问题的潜在治疗方法.
科学领域:
- 眼科医生 眼科 眼科
- 内分泌学 在内分泌学.
- 神经学 神经学
背景情况:
- 该患者有小β血病史,带有视网膜病变的糖尿病和缺铁性贫血.
- 双眼双眼症带来了重大管理挑战,特别是在有复杂病史的患者中.
相关概念视频
Open Angle Glaucoma: Treatment
413
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
413
Angle Closure Glaucoma: Treatment
454
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
454
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
98
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
98


